Subscribe to RSS

DOI: 10.1055/s-0045-1809423
Iodine-Negative Rare Gluteal Muscle Metastasis of Papillary Thyroid Cancer: Detected by 68Ga-DOTATATE PET/MRI and 18F-FDG PET/CT

Abstract
The case presents a 57-year-old male with metastatic papillary thyroid carcinoma (PTC) to the lymph nodes, lung, and mediastinum. Despite receiving multiple high-dose radioactive iodine (RAI) therapies, the patient's serum thyroglobulin levels continued to rise. The patient, who was unresponsive to RAI therapy, was being evaluated for suitability for 177Lu-DOTATATE therapy. Therefore, after the third high-dose treatment, simultaneous 68Ga-DOTATATE PET/MRI and 18F FDG PET/CT imaging were performed, revealing a painless mass in the left gluteal region. The gluteal mass was excised, and histopathology confirmed it as metastatic PTC. Muscle metastases are extremely rare for PTC. This case exemplifies the different levels of tumoral affinity shown by aggressive variants of PTC across three distinct imaging modalities: 68Ga-DOTATATE PET/MRI, 18F FDG PET/CT, and whole-body iodine scintigraphy.
Keywords
papillary thyroid carcinoma - gluteal muscles - RAI-refractory - 68Ga-DOTATATE PET/MRI - 18F-FDG PET/CTPublication History
Article published online:
03 June 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet 2016; 388 (10061): 2783-2795
- 2 Hirsch D, Levy S, Tsvetov G. et al. Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases. Endocr Pract 2017; 23 (10) 1193-1200
- 3 Herbowski L. Skeletal muscle metastases from papillary and follicular thyroid carcinomas: an extensive review of the literature. Oncol Lett 2018; 15 (05) 7083-7089
- 4 Bruglia M, Palmonella G, Silvetti F. et al. Skin and thigh muscle metastasis from papillary thyroid cancer. Singapore Med J 2009; 50 (02) e61-e64
- 5 Haugen BR, Alexander EK, Bible KC. et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (01) 1-133
- 6 Hitu L, Cainap C, Apostu D. et al. Skeletal muscle metastasis in papillary thyroid microcarcinoma evaluated by F18-FDG PET/CT. Diagnostics (Basel) 2020; 10 (02) 10
- 7 Yang J, Li LF, Zhang XM. et al. Unusual synchronous skeletal muscle and lung metastasis in papillary thyroid cancer: a case report and review of the literature. Oncol Lett 2015; 9 (02) 727-730
- 8 Almeida LS, Araújo MC, Zantut-Wittmann DE. et al. Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study. Nucl Med Commun 2018; 39 (05) 441-450
- 9 Binse I, Poeppel TD, Ruhlmann M. et al. 68Ga-DOTATOC PET/CT in patients with iodine- and 18F-FDG-negative differentiated thyroid carcinoma and elevated serum thyroglobulin. J Nucl Med 2016; 57 (10) 1512-1517